Nanotechnology in Battle Against Coronavirus

Since the flare-up started in late 2019, specialists have been hustling to become familiar with SARS-CoV-2, which is a strain from a group of infections known as Covid for their crown-like shape. Northeastern synthetic architect Thomas Webster, who works in creating nano-scale medication and innovation to treat illnesses, is important for a possibility of researchers that are contributing thoughts and innovation to the Centers for Disease Control and Prevention to battle the COVID-19 flare-up. Using nanoparticles, Webster says, is that the infection behind COVID-19 comprises of a structure of a comparative scale as his nanoparticles. At that scale, matter is super little, around multiple times littler than the width of a solitary strand of hair. Webster is proposing particles of comparative sizes that could append to SARS-CoV-2 infections, upsetting their structure with a mix of infrared light treatment. That auxiliary change would then end the capacity of the infection to endure and recreate in the body.

  • Prevention, diagnosis and treatment of COVID-19
  • Fields of science and technology
  • global health emergency

Related Conference of Nanotechnology in Battle Against Coronavirus

April 17-18, 2023

35th Nano Congress for Future Advancements

Paris, France
June 26-27, 2023

40th Global Summit on Nanoscience and Technology

Tokyo, Japan
July 05-06, 2023

40th Global Nanotechnology Congress

Paris, France
August 14-15, 2023

26th World Nanotechnology Congress

Dublin, Ireland
September 27-28, 2023

32nd International Conference on Nanomedicine & Drug Delivery

Zurich, Switzerland
October 16-17, 2023

34th World Nano Conference

Vancouver, Canada
November 08-09, 2023

4th World Congress on Nanotechnology and Advanced Materials

Budapest, Hungary
December 04-05, 2023

31st International Conference on Nanomedicine and Nanomaterials

Prague, Czech Republic

Nanotechnology in Battle Against Coronavirus Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in